X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (575) 575
Publication (82) 82
Book / eBook (15) 15
Book Review (13) 13
Book Chapter (10) 10
Web Resource (4) 4
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (345) 345
female (290) 290
oncology (260) 260
aged (246) 246
middle aged (179) 179
index medicus (162) 162
breast cancer (137) 137
breast neoplasms - drug therapy (129) 129
adult (126) 126
aged, 80 and over (113) 113
chemotherapy (107) 107
cancer (99) 99
male (81) 81
breast neoplasms - pathology (74) 74
antineoplastic combined chemotherapy protocols - therapeutic use (64) 64
women (61) 61
health aspects (54) 54
article (52) 52
chemotherapy, adjuvant (51) 51
geriatric assessment (51) 51
treatment outcome (50) 50
age factors (48) 48
breast neoplasms - therapy (48) 48
care and treatment (48) 48
neoplasm staging (45) 45
survival (44) 44
therapy (44) 44
breast neoplasms - mortality (43) 43
prognosis (43) 43
risk factors (40) 40
age (39) 39
quality of life (39) 39
research (38) 38
analysis (37) 37
clinical trials as topic (37) 37
comorbidity (37) 37
quality-of-life (37) 37
antineoplastic agents - therapeutic use (35) 35
medicine & public health (35) 35
geriatric oncology (33) 33
neoplasm metastasis (33) 33
adjuvant chemotherapy (32) 32
drug evaluation (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (31) 31
elderly-patients (31) 31
hematology, oncology and palliative medicine (30) 30
combined modality therapy (29) 29
cyclophosphamide - administration & dosage (29) 29
geriatrics & gerontology (29) 29
drug administration schedule (28) 28
endocrine therapy (28) 28
randomized-trial (28) 28
time factors (28) 28
antineoplastic agents - adverse effects (27) 27
doxorubicin - administration & dosage (27) 27
survival analysis (27) 27
tamoxifen (26) 26
diagnosis (25) 25
antineoplastic agents, hormonal - therapeutic use (24) 24
breast neoplasms - diagnosis (24) 24
cyclophosphamide (24) 24
disease-free survival (24) 24
fluorouracil - administration & dosage (24) 24
postmenopausal women (24) 24
drug therapy, combination (23) 23
older people (23) 23
adjuvant treatment (22) 22
aged patients (22) 22
dose-response relationship, drug (22) 22
toxicity (22) 22
breast neoplasms - surgery (21) 21
breast-cancer (21) 21
follow-up studies (21) 21
lymphatic metastasis (21) 21
tamoxifen - therapeutic use (21) 21
vincristine - administration & dosage (21) 21
activities of daily living (20) 20
aging (20) 20
antineoplastic agents - administration & dosage (20) 20
elderly (20) 20
retrospective studies (20) 20
cancer patients (19) 19
clinical trials (19) 19
internal medicine (19) 19
prospective studies (19) 19
tumors (19) 19
united states (19) 19
drug therapy (18) 18
follow-up (18) 18
mortality (18) 18
surveys and questionnaires (18) 18
survival rate (18) 18
adults (17) 17
breast neoplasms - metabolism (17) 17
doxorubicin (17) 17
methotrexate - administration & dosage (17) 17
patients (17) 17
receptors, estrogen - analysis (17) 17
survivors (17) 17
abridged index medicus (16) 16
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (6) 6
Robarts - Stacks (6) 6
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Baycrest Hospital - Stacks (1) 1
Mathematical Sciences - Stacks (1) 1
Music - Stacks (1) 1
Royal Ontario Museum - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ONCOLOGY (United States), ISSN 0890-9091, 12/2013, Volume 27, Issue 12, pp. 1185 - 1262
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9707, pp. 2055 - 2063
Summary Background Tamoxifen is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of... 
Internal Medicine | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | METHOTREXATE | ANTAGONISM | CARCINOMA | FLUOROURACIL CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Lymph Nodes - pathology | Humans | Middle Aged | Receptors, Estrogen - analysis | Antineoplastic Agents, Alkylating - administration & dosage | Tamoxifen - administration & dosage | Antimetabolites, Antineoplastic - administration & dosage | Receptors, Progesterone - analysis | Fluorouracil - administration & dosage | Postmenopause | Adult | Female | Chemotherapy, Adjuvant | Doxorubicin - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Lymphatic Metastasis | Adenocarcinoma - drug therapy | Breast Neoplasms - drug therapy | Antibiotics, Antineoplastic - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Adenocarcinoma - mortality | Adjuvant treatment | Breast cancer | Dosage and administration | Research | Drug therapy | Tamoxifen | Health aspects | Cancer | Heart failure | Chemotherapy | Womens health | Mortality | Clinical trials | Mammography | Radiation therapy | Cancer therapies | Tumors | Toxicity | Leukemia | Congestive heart failure | Doxorubicin | Subgroups | Rank tests | Randomization | Motivation | Registration | Mastectomy | Thromboembolism | Neutropenia | Review boards | Regression analysis | Patients | Survival | Post-menopause | Stomatitis | Cyclophosphamide | Anthracycline | Breast | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2009, Volume 360, Issue 20, pp. 2055 - 2065
This trial compared standard multiagent chemotherapy with a single agent (capecitabine) as adjuvant therapy for breast cancer in women 65 years of age or... 
SURVIVAL | TRIAL | MEDICINE, GENERAL & INTERNAL | THERAPY | CYCLOPHOSPHAMIDE | DOXORUBICIN | FOLLOW-UP | PHASE-II | DOSE-INTENSITY | CONSENSUS RECOMMENDATIONS | AGE | Breast Neoplasms - surgery | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Capecitabine | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Receptors, Estrogen - analysis | Methotrexate - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Neoplasm Metastasis | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Chemotherapy, Adjuvant - adverse effects | Aged, 80 and over | Deoxycytidine - adverse effects | Female | Doxorubicin - administration & dosage | Fluorouracil - analogs & derivatives | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Breast Neoplasms - drug therapy | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Antimetabolites, Antineoplastic - adverse effects | Survival Analysis | Methotrexate - administration & dosage | Aged | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Evaluation | Care and treatment | Usage | Aged women | Adjuvant treatment | Breast cancer | Comparative analysis | Health aspects | Cancer | Chemotherapy | Toxicity | Leukemia | Age | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2014, Volume 32, Issue 19, pp. 1996 - 2000
Journal Article
2000, Basic and clinical oncology, ISBN 9780824702786, Volume 23, xiv, 606
This book presents comprehensive assessment and up-to-date discussion of the epidemiology, prevention, and treatment of cancer in the elderly, highlighting the... 
epidemiology | Aged | prevention & control | therapy | Geriatric oncology | Neoplasms | Oncology | Gerontology
Book
Journal of oncology practice, 10/2018, p. JOP1800120
Because of the escalating cost of cancer care coupled with high insurance deductibles, premiums, and uninsured populations, patients with cancer are affected... 
Journal Article
Journal Article
Journal Article